Linagliptin
98%
- Product Code: 50914
CAS:
668270-12-0
| Molecular Weight: | 472.54 g./mol | Molecular Formula: | C₂₅H₂₈N₈O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD14635356 | |
| Melting Point: | 187-190ºC | Boiling Point: | |
| Density: | Storage Condition: | 2-8ºC |
Product Description:
Linagliptin is primarily used in the management of type 2 diabetes mellitus. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps to increase the levels of incretin hormones. These hormones play a crucial role in regulating blood glucose levels by enhancing insulin secretion and suppressing glucagon release after meals.
The medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. It is particularly beneficial for patients who require an oral antidiabetic agent with a low risk of hypoglycemia. Linagliptin is also advantageous for individuals with renal impairment, as it does not require dosage adjustment in such cases.
In clinical practice, Linagliptin is sometimes combined with other antidiabetic medications like metformin to achieve better glycemic control. Its once-daily dosing regimen improves patient compliance, making it a convenient option for long-term diabetes management.
Overall, Linagliptin is a valuable therapeutic option for improving glycemic control in patients with type 2 diabetes, offering a favorable safety profile and ease of use.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | SOLID |
| PURITY | 98-100 |
| MELTING POINT | 195-210 |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿750.00 |
+
-
|
| 1.000 | 10-20 days | ฿1,750.00 |
+
-
|
| 5.000 | 10-20 days | ฿5,280.00 |
+
-
|
| 25.000 | 10-20 days | ฿23,600.00 |
+
-
|
Linagliptin
Linagliptin is primarily used in the management of type 2 diabetes mellitus. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps to increase the levels of incretin hormones. These hormones play a crucial role in regulating blood glucose levels by enhancing insulin secretion and suppressing glucagon release after meals.
The medication is often prescribed as part of a comprehensive treatment plan that includes diet and exercise. It is particularly beneficial for patients who require an oral antidiabetic agent with a low risk of hypoglycemia. Linagliptin is also advantageous for individuals with renal impairment, as it does not require dosage adjustment in such cases.
In clinical practice, Linagliptin is sometimes combined with other antidiabetic medications like metformin to achieve better glycemic control. Its once-daily dosing regimen improves patient compliance, making it a convenient option for long-term diabetes management.
Overall, Linagliptin is a valuable therapeutic option for improving glycemic control in patients with type 2 diabetes, offering a favorable safety profile and ease of use.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :